Artificial Intelligence in Colorectal Disease
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Machine Learning and Artificial Intelligence in Diagnostics".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 1248
Special Issue Editor
Special Issue Information
Dear Colleagues,
Artificial intelligence is becoming increasingly important in the detection and personalized treatment of cancer. The applications to clinical workflows can include tumour burden annotation as well as treatment response assessment and prediction together with recurrence and metastasis prediction. All of these use cases are relevant for colorectal cancer, which is among the four most common cancers. The long-term survival of colorectal cancer patients has improved considerably for some types, such as locally advanced rectal cancer with the introduction of total mesorectal excision. However, mortality, particularly in elderly populations, remains high. In addition, treatment can have significant impacts on quality of life such as colostomy and long-term comorbidities. This presents significant opportunities for personalised treatment, in which AI models can identify which patients will have a low chance of recurrence, thereby preventing unnecessary comorbidities. With the relatively large datasets provided by colorectal cancer cohorts, the possibilities provided by artificial intelligence can have a real impact to both the survival and quality of life of colorectal cancer patients.
Dr. Sean Benson
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
